Circulating tumor DNA analysis of metastatic renal cell carcinoma

被引：7

作者：

Zhang, Jingbo ^{[1
]}

Liu, Yunchao ^{[1
]}

Xu, Bing ^{[1
]}

Li, Fuwei ^{[1
]}

Wang, Yan ^{[1
]}

Li, Mengjian ^{[1
]}

Du, Rong ^{[1
]}

Zhou, Ye ^{[1
]}

Salgia, Meghan ^{[2
]}

Yang, Lixin ^{[2
]}

Jones, Jeremy O. ^{[2
]}

机构：

[1] Beijing USCI Med Lab, Beijing 100049, Peoples R China

[2] City Hope Med Ctr, Dept Med Oncol, 1500 East Duarte Rd, Duarte, CA 91010 USA

来源：

MOLECULAR AND CLINICAL ONCOLOGY | 2021年 / 14卷 / 01期

关键词：

metastasis; renal cell carcinoma; circulating tumor DNA; PATHWAY; CANCER;

D O I：

10.3892/mco.2020.2178

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The genomic landscape of metastatic renal cell carcinoma (RCC) is not well understood, and currently available data suggest that it is functionally distinct from that of localized tumors. Additionally, the large number of approved and trial agents used to treat metastatic RCC likely cause selective adaptations in the tumors. Circulating tumor DNA (ctDNA) is a platform to non-invasively determine the genomic profiles of these tumors. The objectives of the present study were to corroborate previous ctDNA studies in metastatic RCC, to identify novel mutations in metastatic RCC, and to compare ctDNA profiles obtained from plasma and urine in patients with metastatic RCC. ctDNA sequencing using the plasma and urine of 50 patients with metastatic RCC who received ctDNA profiling as part of routine clinical care at a single institution was performed using an investigational 120-gene panel. Genomic alterations (GAs) were identified in all 50 patients. The genes with the most GAs were GNAS, PTEN, MYC, MET and HNF1A and novel mutations in additional genes were identified. A significant correlation between the number of GAs detected in matched urine and plasma samples was also identified, but only 28.1% of GAs detected in plasma samples were also detected in matched urine samples. The results of the present study were consistent with those of the largest previous study of ctDNA from patients with metastatic RCC and may help identify additional potential targets for the treatment of such patients.

引用

页码：1 / 5

页数：5

共 20 条

[1] Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer [J].

Bahcall, Magda ;

Sim, Taebo ;

Paweletz, Cloud P. ;

Patel, Jyoti D. ;

Alden, Ryan S. ;

Kuang, Yanan ;

Sacher, Adrian G. ;

Kim, Nam Doo ;

Lydon, Christine A. ;

Awad, Mark M. ;

Jaklitsch, Michael T. ;

Sholl, Lynette M. ;

Jaenne, Pasi A. ;

Oxnard, Geoffrey R. .

CANCER DISCOVERY, 2016, 6 (12) :1334-1341

[2] The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data [J].

Cerami, Ethan ;

Gao, Jianjiong ;

Dogrusoz, Ugur ;

Gross, Benjamin E. ;

Sumer, Selcuk Onur ;

Aksoy, Buelent Arman ;

Jacobsen, Anders ;

Byrne, Caitlin J. ;

Heuer, Michael L. ;

Larsson, Erik ;

Antipin, Yevgeniy ;

Reva, Boris ;

Goldberg, Arthur P. ;

Sander, Chris ;

Schultz, Nikolaus .

CANCER DISCOVERY, 2012, 2 (05) :401-404

[3] Comprehensivemolecular characterization of clear cell renal cell carcinoma [J].

Creighton, Chad J. ;

Morgan, Margaret ;

Gunaratne, Preethi H. ;

Wheeler, David A. ;

Gibbs, Richard A. ;

Robertson, A. Gordon ;

Chu, Andy ;

Beroukhim, Rameen ;

Cibulskis, Kristian ;

Signoretti, Sabina ;

Vandin, Fabio ;

Wu, Hsin-Ta ;

Raphael, Benjamin J. ;

Verhaak, Roel G. W. ;

Tamboli, Pheroze ;

Torres-Garcia, Wandaliz ;

Akbani, Rehan ;

Weinstein, John N. ;

Reuter, Victor ;

Hsieh, James J. ;

Brannon, A. Rose ;

Hakimi, A. Ari ;

Jacobsen, Anders ;

Ciriello, Giovanni ;

Reva, Boris ;

Ricketts, Christopher J. ;

Linehan, W. Marston ;

Stuart, Joshua M. ;

Rathmell, W. Kimryn ;

Shen, Hui ;

Laird, Peter W. ;

Muzny, Donna ;

Davis, Caleb ;

Morgan, Margaret ;

Xi, Liu ;

Chang, Kyle ;

Kakkar, Nipun ;

Trevino, Lisa R. ;

Benton, Susan ;

Reid, Jeffrey G. ;

Morton, Donna ;

Doddapaneni, Harsha ;

Han, Yi ;

Lewis, Lora ;

Dinh, Huyen ;

Kovar, Christie ;

Zhu, Yiming ;

Santibanez, Jireh ;

Wang, Min ;

Hale, Walker .

NATURE, 2013, 499 (7456) :43-+

[4] Significance of PTEN Mutation in Cellular Process, Prognosis, and Drug Selection in Clear Cell Renal Cell Carcinoma [J].

Fan, Caibin ;

Zhao, Chunchun ;

Wang, Fei ;

Li, Shugen ;

Wang, Jianqing .

FRONTIERS IN ONCOLOGY, 2019, 9

[5] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].

Ferlay, Jacques ;

Soerjomataram, Isabelle ;

Dikshit, Rajesh ;

Eser, Sultan ;

Mathers, Colin ;

Rebelo, Marise ;

Parkin, Donald Maxwell ;

Forman, David ;

Bray, Freddie .

INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386

[6] Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers [J].

Fujii, Takeo ;

Barzi, Afsaneh ;

Sartore-Bianchi, Andrea ;

Cassingena, Andrea ;

Siravegna, Giulia ;

Karp, Daniel D. ;

Piha-Paul, Sarina A. ;

Subbiah, Vivek ;

Tsimberidou, Apostolia M. ;

Huang, Helen J. ;

Veronese, Silvio ;

Di Nicolantonio, Federica ;

Pingle, Sandeep ;

Vibat, Cecile Rose T. ;

Hancock, Saege ;

Berz, David ;

Melnikova, Vladislava O. ;

Erlander, Mark G. ;

Luthra, Rajyalakshmi ;

Kopetz, E. Scott ;

Meric-Bernstam, Funda ;

Siena, Salvatore ;

Lenz, Heinz-Josef ;

Bardelli, Alberto ;

Janku, Filip .

CLINICAL CANCER RESEARCH, 2017, 23 (14) :3657-3666

[7] Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas [J].

Furukawa, Toru ;

Kuboki, Yuko ;

Tanji, Etsuko ;

Yoshida, Shoko ;

Hatori, Takashi ;

Yamamoto, Masakazu ;

Shibata, Noriyuki ;

Shimizu, Kyoko ;

Kamatani, Naoyuki ;

Shiratori, Keiko .

SCIENTIFIC REPORTS, 2011, 1

[8] Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer [J].

Gainor, Justin F. ;

Dardaei, Leila ;

Yoda, Satoshi ;

Friboulet, Luc ;

Leshchiner, Ignaty ;

Katayama, Ryohei ;

Dagogo-Jack, Ibiayi ;

Gadgeel, Shirish ;

Schultz, Katherine ;

Singh, Manrose ;

Chin, Emily ;

Parks, Melissa ;

Lee, Dana ;

DiCecca, Richard H. ;

Lockerman, Elizabeth ;

Huynh, Tiffany ;

Logan, Jennifer ;

Ritterhouse, Lauren L. ;

Le, Long P. ;

Muniappan, Ashok ;

Digumarthy, Subba ;

Channick, Colleen ;

Keyes, Colleen ;

Getz, Gad ;

Dias-Santagata, Dora ;

Heist, Rebecca S. ;

Lennerz, Jochen ;

Sequist, Lecia V. ;

Benes, Cyril H. ;

Iafrate, A. John ;

Mino-Kenudson, Mari ;

Engelman, Jeffrey A. ;

Shaw, Alice T. .

CANCER DISCOVERY, 2016, 6 (10) :1118-1133

[9] Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review [J].

Gupta, Kiran ;

Miller, Jeffrey D. ;

Li, Jim Z. ;

Russel, Mason W. ;

Charbonneau, Claudie .

CANCER TREATMENT REVIEWS, 2008, 34 (03) :193-205

[10] Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma [J].

Linehan, W. Marston ;

Spellman, Paul T. ;

Ricketts, Christopher J. ;

Creighton, Chad J. ;

Fei, Suzanne S. ;

Davis, Caleb ;

Wheeler, David A. ;

Murray, Bradley A. ;

Schmidt, Laura ;

Vocke, Cathy D. ;

Peto, Myron ;

Al Mamun, Abu Amar M. ;

Shinbrot, Eve ;

Sethi, Anurag ;

Brooks, Samira ;

Rathmell, W. Kimryn ;

Brooks, Angela N. ;

Hoadley, Katherine A. ;

Robertson, A. Gordon ;

Brooks, Denise ;

Bowlby, Reanne ;

Sadeghi, Sara ;

Shen, Hui ;

Weisenberger, Daniel J. ;

Bootwalla, Moiz ;

Baylin, Stephen B. ;

Laird, Peter W. ;

Cherniack, Andrew D. ;

Saksena, Gordon ;

Haake, Scott ;

Li, Jun ;

Liang, Han ;

Lu, Yiling ;

Mills, Gordon B. ;

Akbani, Rehan ;

Leiserson, Mark D. M. ;

Raphael, Benjamin J. ;

Anur, Pavana ;

Bottaro, Donald ;

Albiges, Laurence ;

Barnabas, Nandita ;

Choueiri, Toni K. ;

Czerniak, Bogdan ;

Godwin, Andrew K. ;

Hakimi, A. Ari ;

Ho, Thai H. ;

Hsieh, James ;

Ittmann, Michael ;

Kim, William Y. ;

Krishnan, Bhavani .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (02) :135-145

← 1 2 →